Ancient and modern medication laws of aromatic Chinese medicines in treating angina pectoris based on data mining

Wang, Chaoping; Luo, Jianxun; Wan, Qiang; Meifang, Cao; Zha, Qinglin; Li, Zhiqiang; Naeem, Abid; Yang, Ming–Hsuan

doi:10.1016/j.dcmed.2022.06.003

Cited by 2 publications

(1 citation statement)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The theoretical basis of TCM represents rich and invaluable treasure house of medical experience that has been passed down for thousands of years. Exploring TCM theory and ancient literature deeply is crucial for promoting the inheritance and development of this medical cultural heritage (Xu et al, 2020;Chaoping et al, 2022). However, numerous ancient TCM documents have been destroyed and scattered across the country, with their compilation methods differing from modern standards, making them difficult to access and query.…”

Section: Experience Of Respected Senior Tcm Practitionersmentioning

confidence: 99%

Integrating artificial intelligence into the modernization of traditional Chinese medicine industry: a review

Zhou,

Shen,

Hou

2024

Front. Pharmacol.

View full text Add to dashboard Cite

Traditional Chinese medicine (TCM) is the practical experience and summary of the Chinese nation for thousands of years. It shows great potential in treating various chronic diseases, complex diseases and major infectious diseases, and has gradually attracted the attention of people all over the world. However, due to the complexity of prescription and action mechanism of TCM, the development of TCM industry is still in a relatively conservative stage. With the rise of artificial intelligence technology in various fields, many scholars began to apply artificial intelligence technology to traditional Chinese medicine industry and made remarkable progress. This paper comprehensively summarizes the important role of artificial intelligence in the development of traditional Chinese medicine industry from various aspects, including new drug discovery, data mining, quality standardization and industry technology of traditional Chinese medicine. The limitations of artificial intelligence in these applications are also emphasized, including the lack of pharmacological research, database quality problems and the challenges brought by human-computer interaction. Nevertheless, the development of artificial intelligence has brought new opportunities and innovations to the modernization of traditional Chinese medicine. Integrating artificial intelligence technology into the comprehensive application of Chinese medicine industry is expected to overcome the major problems faced by traditional Chinese medicine industry and further promote the modernization of the whole traditional Chinese medicine industry.

show abstract

Section: Experience Of Respected Senior Tcm Practitionersmentioning

confidence: 99%

Integrating artificial intelligence into the modernization of traditional Chinese medicine industry: a review

Zhou,

Shen,

Hou

2024

Front. Pharmacol.

View full text Add to dashboard Cite

show abstract

Pharmacoeconomic Evaluation of Conservative and Interventional Management in patients with Coronary Artery Disease: Real World Data

Karunanithi,

et al. 2024

RJPT

View full text Add to dashboard Cite

Objectives: The study tackles evaluating and comparing the cost-effectiveness of Conservative and Interventional Management in patients with CAD from the payer’s perspective concerning real-world data. Methodology: The pharmacoeconomic analysis consisted of an ICER calculation quadrant and a decision tree that reflected the most economically advantageous course of treatment, whether it be conservative or interventional. The costs for the interventional and conservative therapy were taken from The Government of Tamil Nadu, the Chief Minister's Comprehensive Health Insurance Scheme, and the Pharmacy of the multispecialty hospital, and the SF-36 Questionnaire was used to measure patients' health-related quality of life. Result: 126 patients were included. The SF-36 score 1 and 3 QoL comparison between conservative and interventional management had a high level of significance (p values = 0.00349 and 0.0035, respectively). When comparing the costs of conservative and interventional management, the results were extremely significant (p-value 0.001). For patients receiving interventional management, the average medical expense is higher (Rs 1, 41, 784 vs. Rs 38, 388). Patients with CAD receiving conservative therapy had an average HRQol score that was higher (52.32 vs. 39.64). The overall ICER of conservative versus interventional management in terms of life years saved was Rs 8,154. Conclusion: CAD patients receiving Interventional management has higher average medical cost than conservative management. CAD patients receiving conservative management had a higher average HRQol. ICER of conservative versus interventional management in all age groups was Rs 8,154/life years saved. Conservative management was more Cost- Effective than interventional.

show abstract

Ancient and modern medication laws of aromatic Chinese medicines in treating angina pectoris based on data mining

Cited by 2 publications

References 3 publications

Integrating artificial intelligence into the modernization of traditional Chinese medicine industry: a review

Integrating artificial intelligence into the modernization of traditional Chinese medicine industry: a review

Pharmacoeconomic Evaluation of Conservative and Interventional Management in patients with Coronary Artery Disease: Real World Data

Contact Info

Product

Resources

About